• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by DraftKings Inc.

    5/13/25 9:36:10 PM ET
    $DKNG
    Services-Misc. Amusement & Recreation
    Consumer Discretionary
    Get the next $DKNG alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001810231
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    DraftKings Inc.
    SEC File Number
    001-41379
    Address of Issuer
    222 BERKELEY STREET
    BOSTON
    MASSACHUSETTS
    02116
    Phone
    617-986-6744
    Name of Person for Whose Account the Securities are To Be Sold
    Robins Jason
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Officer, Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    Class A Common Stock
    Morgan Stanley & Co. LLC
    1585 Broadway
    New York � NY � 10036
    30699711665886.0049628563105/13/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    Class A Common Stock03/14/2023Acquired as compensation -- Restricted Stock AwardsDraftKings Inc.Checkbox not checked16176703/14/2023Compensation
    Class A Common Stock03/14/2023Acquired as compensation -- Restricted Stock AwardsDraftKings Inc.Checkbox not checked7579903/14/2023Compensation
    Class A Common Stock06/29/2023Acquired as compensation -- Restricted Stock AwardsDraftKings Inc.Checkbox not checked2130206/29/2023Compensation
    Class A Common Stock03/19/2024Acquired as compensation -- Restricted Stock AwardsDraftKings Inc.Checkbox not checked2240603/19/2024Compensation
    Class A Common Stock04/23/2024Acquired as compensation -- Restricted Stock AwardsDraftKings Inc.Checkbox not checked598404/23/2024Compensation
    Class A Common Stock05/09/2024Acquired as compensation -- Restricted Stock AwardsDraftKings Inc.Checkbox not checked1973905/09/2024Compensation

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Name and Address of SellerTitle of Securities SoldDate of SaleAmount of Securities SoldGross Proceeds
    Jason Robins
    222 Berkeley Street
    5th Floor
    Boston � MA � 02116
    Class A Common Stock03/14/202571555126833162.50
    Jason Robins
    222 Berkeley Street
    5th Floor
    Boston � MA � 02116
    Class A Common Stock02/25/202566665128280068.73

    144: Remarks and Signature

    Remarks
    Seller represents that the sale reported in Table I was made pursuant to a stock purchase agreement in respect of a variable price forward sale transaction (the Forward Contract) between Seller and the broker named in Table I. The Forward Contract provides for settlement based on the closing price of the Issuer's Class A Common Shares on the maturity date, May 13, 2030. Any initial hedging activity in connection with the Transaction will be conducted by the broker named in Table I. As listed in Table II, Seller further represents that the sale of 715,551 shares on March 14, 2025 was made pursuant to a stock purchase agreement in respect of a variable price forward sale transaction. Additionally, Seller represents that the sale of 666,651 shares of Issuer's Class A Common Stock on February 25, 2025 was made pursuant to a Rule 10b5-1 trading plan in order to cover tax withholding obligations in connection with the vesting of certain performance-based restricted stock units.
    Date of Notice
    05/13/2025

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    /s/ Faisal Hasan, as attorney-in-fact for Jason Robins

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $DKNG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DKNG

    DatePrice TargetRatingAnalyst
    6/4/2025$46.00Outperform
    Bernstein
    4/22/2025$64.00 → $52.00Buy
    BTIG Research
    1/8/2025$56.00 → $54.00Positive
    Susquehanna
    10/18/2024$54.00 → $62.00Outperform
    Mizuho
    10/7/2024$48.00 → $50.00Positive
    Susquehanna
    9/10/2024$35.00Underperform → Neutral
    Exane BNP Paribas
    9/4/2024$56.00 → $58.00Buy
    UBS
    9/4/2024$47.00 → $48.00Positive
    Susquehanna
    More analyst ratings